ExodusPoint Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

ExodusPoint Capital Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-12,446	Closed	-$1.44M	–	2185
2023 Q3	$1.44M	Sell	12,446 -18,153	-59%	-$1.95M	0.01%	815
2023 Q2	$3.15M	Buy	+30,599	New	+$3.23M	0.03%	622
2022 Q4	–	Sell	-119,485	Closed	-$7.39M	–	2323
2022 Q3	$7.39M	Buy	119,485 +8,664	+8%	+$605K	0.1%	284
2022 Q2	$8.84M	Buy	110,821 +56,558	+104%	+$5.36M	0.11%	219
2022 Q1	$5.71M	Sell	54,263 -7,552	-12%	-$736K	0.07%	336
2021 Q4	$6.66M	Buy	61,815 +9,904	+19%	+$1.08M	0.07%	333
2021 Q3	$5.69M	Buy	+51,911	New	+$5.39M	0.08%	348
2021 Q1	–	Sell	-8,713	Closed	-$637K	–	2858
2020 Q4	$637K	Sell	8,713 -335,855	-97%	-$25M	0.01%	1102
2020 Q3	$26.8M	Buy	344,568 +291,253	+546%	+$20M	0.53%	19
2020 Q2	$2.96M	Buy	+53,315	New	+$2.28M	0.08%	295
2019 Q3	–	Sell	-61,610	Closed	-$1.48M	–	1790
2019 Q2	$1.48M	Buy	+61,610	New	+$1.56M	0.06%	196

Other funds holding HZNP

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

ExodusPoint Capital Management's HZNP Position: Q4 2023 in Review

ExodusPoint Capital Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 12,446 shares — an estimated $1.44M sold.

ExodusPoint Capital Management first reported a position in HZNP in Q2 2019 and held it in 11 quarters. The position peaked at $26.8M in Q3 2020. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

ExodusPoint Capital Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
ExodusPoint Capital Management sold 12,446 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $1.44M.
ExodusPoint Capital Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2019 and held it in 11 quarters.
ExodusPoint Capital Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $26.8M in Q3 2020.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on ExodusPoint Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.